121. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis.
作者: Long Jiang.;Wenhua Liang.;Jianfei Shen.;Xiaofang Chen.;Xiaoshun Shi.;Jiaxi He.;Chenglin Yang.;Jianxing He.
来源: Chest. 2015年148卷4期903-911页
Visceral pleural invasion (VPI) is considered an aggressive and invasive factor in non-small cell lung cancer (NSCLC). Recent studies found that depending on tumor size, VPI influences T stage, but there is no consensus on whether VPI is important in node-negative NSCLC. In addition, its role in stage IB NSCLC is still uncertain. In this meta-analysis, we assessed the role of VPI in node-negative NSCLC according to various tumor sizes and especially in stage IB disease.
122. Is quadriceps endurance reduced in COPD?: a systematic review.
作者: Rachael A Evans.;Eric Kaplovitch.;Marla K Beauchamp.;Thomas E Dolmage.;Roger S Goldstein.;Clare L Gillies.;Dina Brooks.;Sunita Mathur.
来源: Chest. 2015年147卷3期673-684页
Although the aerobic profile of the quadriceps muscle is reduced in COPD, there is conflicting evidence regarding whether this leads to reduced quadriceps muscle endurance. We, therefore, performed a systematic review of studies comparing quadriceps endurance in individuals with COPD with that in healthy control subjects.
123. Self-management following an acute exacerbation of COPD: a systematic review.
作者: Samantha L Harrison.;Tania Janaudis-Ferreira.;Dina Brooks.;Laura Desveaux.;Roger S Goldstein.
来源: Chest. 2015年147卷3期646-661页
Self-management (SM) reduces hospital admissions in patients with stable COPD. However, its role immediately post-acute exacerbation (AE) is unclear. The objectives of this review were to describe SM interventions delivered immediately following an AE of COPD (AECOPD) and to conduct a systematic review with meta-analysis of its impact on health-care utilization and health outcomes.
124. Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies.
作者: Martina Bonifazi.;Francesca Bravi.;Stefano Gasparini.;Carlo La Vecchia.;Armando Gabrielli.;Athol U Wells.;Elisabetta A Renzoni.
来源: Chest. 2015年147卷3期778-791页
An increased cancer risk in patients with sarcoidosis has been suggested, although results are conflicting in a number of case-control and cohort studies. We conducted a systematic review of all available data and performed a meta-analysis to better define and quantify the association between sarcoidosis and cancer.
125. What is the role of tiotropium in asthma?: a systematic review with meta-analysis.
The role of tiotropium for the treatment of asthma has not yet been clearly defined. The aim of this systematic review was to assess the efficacy and safety of tiotropium in patients with asthma.
126. Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis.
作者: Christine G Kohn.;Elizabeth S Mearns.;Matthew W Parker.;Adrian V Hernandez.;Craig I Coleman.
来源: Chest. 2015年147卷4期1043-1062页
Studies suggest outpatient treatment or early discharge of patients with acute pulmonary embolism (aPE) is reasonable for those deemed to be at low risk of early mortality. We sought to determine clinical prediction rule accuracy for identifying patients with aPE at low risk for mortality.
127. Single-dose etomidate does not increase mortality in patients with sepsis: a systematic review and meta-analysis of randomized controlled trials and observational studies.
The effect of single-dose etomidate on mortality in patients with sepsis remains controversial. We systematically reviewed the literature to investigate whether a single dose of etomidate for rapid sequence intubation increased mortality in patients with sepsis.
128. Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis.
作者: Maria Cristina Vedovati.;Federico Germini.;Giancarlo Agnelli.;Cecilia Becattini.
来源: Chest. 2015年147卷2期475-483页
Direct oral anticoagulants (DOAs) have been shown to be as effective and at least as safe as conventional anticoagulation for the prevention of recurrences in patients with VTE. Whether this is the case in patients with cancer-associated VTE remains undefined.
129. Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
作者: José M Porcel.;Paula Hernández.;Montserrat Martínez-Alonso.;Silvia Bielsa.;Antonieta Salud.
来源: Chest. 2015年147卷2期502-512页
The role of fluorodeoxyglucose (FDG)-PET imaging for diagnosing malignant pleural effusions is not well defined. The aim of this study was to summarize the evidence for its use in ruling in or out the malignant origin of a pleural effusion or thickening.
130. Prognostic value of plasma heart-type fatty acid-binding protein in patients with acute pulmonary embolism: a meta-analysis.
Several studies have described heart-type fatty acid-binding protein (H-FABP) from early blood samples as a predictor of outcome in acute pulmonary embolism (PE). This systematic review is designed to determine the prognostic value of H-FABP aimed for use in patients with acute PE.
131. Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials.
作者: Yaa-Hui Dong.;Chia-Hsuin Chang.;Fe-Lin Lin Wu.;Li-Jiuan Shen.;Peter M A Calverley.;Claes-Göran Löfdahl.;Mei-Shu Lai.;Donald A Mahler.
来源: Chest. 2014年145卷6期1286-1297页
Background: The use of inhaled corticosteroids (ICSs) is associated with an increased risk of pneumonia in patients with COPD. However, the risks of other respiratory infections, such as TB and influenza, remain unclear.Methods: Through a comprehensive literature search of MEDLINE, EMBASE, CINAHL, Cochrane Library, and ClinicalTrials.gov from inception to July 2013, we identified randomized controlled trials of ICS therapy lasting at least 6 months. We conducted meta-analyses by the Peto, Mantel-Haenszel, and Bayesian approaches to generate summary estimates comparing ICS with non-ICS treatment on the risk of TB and influenza.Results: Twenty-fi ve trials (22,898 subjects) for TB and 26 trials (23,616 subjects) for influenza were included. Compared with non-ICS treatment, ICS treatment was associated with a significantly higher risk of TB (Peto OR, 2.29; 95% CI, 1.04-5.03) but not influenza (Peto OR, 1.24;95% CI, 0.94-1.63). Results were similar with each meta-analytic approach. Furthermore, the number needed to harm to cause one additional TB event was lower for patients with COPD treated with ICSs in endemic areas than for those in nonendemic areas (909 vs 1,667, respectively).Conclusions: This study raises safety concerns about the risk of TB and influenza associated with ICS use in patients with COPD, which deserve further investigation.
132. Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis.
作者: Marie Ollier.;Alain Chamoux.;Geraldine Naughton.;Bruno Pereira.;Frédéric Dutheil.
来源: Chest. 2014年145卷6期1339-1346页
Lung cancer is the most frequent malignant asbestos-related pathology and remains the most fatal cancer of industrialized countries. In heavy smokers, early detection of lung cancer with chest CT scan leads to a 20% mortality reduction. However, the use of CT scan screening for early detection of lung cancer in asbestos-exposed workers requires further investigation. This study aimed to determine whether CT scan screening in asbestos-exposed workers is effective in detecting asymptomatic lung cancer using a systematic review and meta-analysis.
133. Comparative effectiveness and safety of drug therapy for pulmonary arterial hypertension: a systematic review and meta-analysis.
作者: Remy R Coeytaux.;Kristine M Schmit.;Bryan D Kraft.;Andrzej S Kosinski.;Alicea M Mingo.;Lisa M Vann.;Daniel L Gilstrap.;C William Hargett.;Brooke Heidenfelder.;Rowena J Dolor.;Douglas C McCrory.
来源: Chest. 2014年145卷5期1055-1063页
Current treatments for pulmonary arterial hypertension (PAH) have been shown to improve dyspnea, 6-min walk distance (6MWD), and pulmonary hemodynamics, but few studies were designed to compare treatment regimens or assess the impact of treatment on mortality.
134. Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials.
作者: Daniel R Morales.;Cathy Jackson.;Brian J Lipworth.;Peter T Donnan.;Bruce Guthrie.
来源: Chest. 2014年145卷4期779-786页
β-Blockers are avoided in asthma over concerns regarding acute bronchoconstriction. Risk is greatest following acute exposure, including the potential for antagonism of β2-agonist rescue therapy.
135. Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis.
作者: Cristiano Fava.;Stefania Dorigoni.;Francesco Dalle Vedove.;Elisa Danese.;Martina Montagnana.;Gian Cesare Guidi.;Krzysztof Narkiewicz.;Pietro Minuz.
来源: Chest. 2014年145卷4期762-771页
CPAP is considered the therapy of choice for OSA, but the extent to which it can reduce BP is still under debate. We undertook a systematic review and meta-analysis of randomized controlled trials (RCTs) to quantify the effect size of the reduction of BP by CPAP therapy compared with other passive (sham CPAP, tablets of placebo drug, conservative measures) or active (oral appliance, antihypertensive drugs) treatments.
136. Diagnostic accuracy and safety of semirigid thoracoscopy in exudative pleural effusions: a meta-analysis.
The usefulness of semirigid thoracoscopy in undiagnosed exudative pleural effusions (EPEs) has been variably reported in different studies. Herein, we perform a systematic review and meta-analysis to estimate the overall diagnostic yield and safety of semirigid thoracoscopy in EPE.
137. Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis.
作者: William S Yancy.;Douglas C McCrory.;Remy R Coeytaux.;Kristine M Schmit.;Alex R Kemper.;Adam Goode.;Victor Hasselblad.;Brooke L Heidenfelder.;Gillian D Sanders.
来源: Chest. 2013年144卷6期1827-1838页
Understanding the comparative effectiveness of treatments for patients with unexplained or refractory cough is important to increase awareness of proven therapies and their potential adverse effects in this unique population.
138. Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis.
作者: George Dimopoulos.;Garyphallia Poulakou.;Ioannis A Pneumatikos.;Apostolos Armaganidis.;Marin H Kollef.;Dimitrios K Matthaiou.
来源: Chest. 2013年144卷6期1759-1767页
We performed a systematic review and meta-analysis of short- vs long-duration antibiotic regimens for ventilator-associated pneumonia (VAP).
139. Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis.
作者: Abhishek Sharma.;Saurav Chatterjee.;Armin Arbab-Zadeh.;Sandeep Goyal.;Edgar Lichstein.;Joydeep Ghosh.;Shamik Aikat.
来源: Chest. 2013年144卷4期1311-1322页
Clinical studies have suggested an association between bisphosphonate use and the onset of atrial fibrillation (AF). However, data on the risk of developing AF, stroke, and cardiovascular mortality with the use of bisphosphonate are conflicting. The objective of this study was to evaluate the risk of serious AF (events that required hospital admission), stroke, and cardiovascular mortality with the use of bisphosphonates through a systematic review of the literature.
140. Relative effects of two different enoxaparin regimens as comparators against newer oral anticoagulants: meta-analysis and adjusted indirect comparison.
作者: Chun Shing Kwok.;Shiva Pradhan.;Jessica Ka-Yan Yeong.;Yoon K Loke.
来源: Chest. 2013年144卷2期593-600页
Two different regimens of enoxaparin (40 mg once daily or 30 mg bid) have been used as control arms in trials of new oral anticoagulants. The choice of enoxaparin comparator may influence the perceived relative efficacy and safety of the newer agents, and we aimed to identify any significant differences between the two enoxaparin regimens.
|